Maurizio Baldassarini
Director/Board Member en TAKE OFF S.P.A. .
Perfil
Maurizio Baldassarini is a founding partner of BOCG Associati since 2005.
He is currently an independent director at VNE SpA, a director at Fenix Entertainment SpA, an independent director at Take Off SpA, and a founding partner at EQValue Srl since 2008.
He was previously an independent non-executive director at Cassiopea SpA from 2018 to 2022 and a professor at Sapienza University of Rome.
He obtained an undergraduate degree from Sapienza University of Rome.
Cargos activos de Maurizio Baldassarini
Empresas | Cargo | Inicio |
---|---|---|
TAKE OFF S.P.A. | Director/Board Member | - |
FENIX ENTERTAINMENT S.P.A. | Director/Board Member | - |
VNE S.P.A. | Director/Board Member | - |
BOCG Associati
BOCG Associati Investment ManagersFinance BOCG Associati provides investment advice. The private company is based in Rome, Italy. The Italian company was founded by Maurizio Baldassarini, Roger Olivieri. | Founder | 01/01/2005 |
EQValue Srl | Private Equity Investor | 01/01/2008 |
Antiguos cargos conocidos de Maurizio Baldassarini.
Empresas | Cargo | Fin |
---|---|---|
CASSIOPEA S.P.A. | Director/Board Member | 01/01/2022 |
Sapienza University of Rome | Corporate Officer/Principal | - |
Formación de Maurizio Baldassarini.
Sapienza University of Rome | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
VNE S.P.A. | Producer Manufacturing |
FENIX ENTERTAINMENT S.P.A. | Consumer Services |
TAKE OFF S.P.A. | Retail Trade |
Empresas privadas | 3 |
---|---|
Cassiopea SpA
Cassiopea SpA Pharmaceuticals: MajorHealth Technology Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The firm's products include Winlevi, Breezula, Clascoterone Solution, CB-06-02, and CB-06-01. The company was founded on July 30, 2013 and is headquartered in Milan, Italy. | Health Technology |
EQValue Srl | |
BOCG Associati
BOCG Associati Investment ManagersFinance BOCG Associati provides investment advice. The private company is based in Rome, Italy. The Italian company was founded by Maurizio Baldassarini, Roger Olivieri. | Finance |
- Bolsa de valores
- Insiders
- Maurizio Baldassarini